Simon Kyaga
Simon Kyaga, MD, Phd, MBA, is Global Medical Director, Alzheimer’s Disease, for Europe Canada and Partner Markets (ECP) at BIOGEN and the co-lead for the MAPS focus area working group on Medical Strategy & Launch Excellence.
Dr. Kyaga has worked in medical affairs positions in different companies spanning from country to regional, and global roles. He completed his doctorate in medicine at the Karolinska Institutet, Stockholm, Sweden before pursuing an internship at the Karolinska Hospital, and residency in Psychiatry. He has a doctorate (PhD) in psychiatric epidemiology using large-scale data, and a Global Executive MBA from INSEAD, Paris, France.
He has a long-standing interest in medical education and previously served as a member of the national board of the Swedish Medical Association, as the scientific secretary of the Swedish Society of Medicine and as medical advisor to the Swedish National Board of Health and Welfare before joining the pharmaceutical industry.
Simon has 20+ years of experience from all aspects of healthcare. Having met more than 10,000 patients in his clinical work, he is passionate about the opportunities of science to bring relief to the patients most in need, and of medical affairs to bring value to healthcare overall.
Charlotte Kremer
Charlotte M. E. Kremer, MD, MBA is formerly the Executive VP and Head of Medical Affairs for Astellas, recently retired. In this role, Dr. Kremer provided leadership for the Medical Affairs organization globally.
Dr. Kremer joined Astellas in 2012 with 20 years of experience in the pharmaceutical industry. Prior to Astellas, she held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical programs in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase 3b/4 clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States. A native of the Netherlands, Dr. Kremer received her medical degree from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.
